Patents Assigned to VAPOGENIX, INC
  • Patent number: 11304913
    Abstract: The present invention provides compositions useful in reducing or preventing pain in a subject in need thereof. In one embodiment, the compositions comprise a halogenated volatile compound. The present invention further includes a method of reducing or preventing pain in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition of the invention. Dosing regimens contemplated within the invention include one-time administration, continuous administration or periodic administration.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: April 19, 2022
    Assignee: Vapogenix, Inc.
    Inventors: Danguole Spakevicius, Heather Giles, Terry Farmer
  • Patent number: 10933009
    Abstract: The present invention provides compositions and methods for treating a dermatological disorder or disease.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: March 2, 2021
    Assignee: Vapogenix, Inc.
    Inventor: Danguole Spakevicius
  • Patent number: 10688062
    Abstract: The present invention provides compositions useful in reducing or preventing pain in a subject in need thereof. In one embodiment, the compositions comprise a halogenated volatile compound. The present invention further includes a method of reducing or preventing pain in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition of the invention. Dosing regimens contemplated within the invention include one-time administration, continuous administration or periodic administration.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: June 23, 2020
    Assignee: Vapogenix, Inc.
    Inventors: Danguole Spakevicius, Heather Giles, Terry Farmer
  • Patent number: 10507189
    Abstract: The present invention provides compositions useful in reducing or preventing pain in a subject in need thereof. In one embodiment, the compositions comprise a halogenated volatile compound. The present invention further includes a method of reducing or preventing pain in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition of the invention. Dosing regimens contemplated within the invention include one-time administration, continuous administration or periodic administration.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: December 17, 2019
    Assignee: Vapogenix, Inc.
    Inventors: Danguole Spakevicius, Heather Giles, Terry Farmer
  • Patent number: 10071065
    Abstract: The present invention provides compositions useful in reducing or preventing pain in a subject in need thereof. In one embodiment, the compositions comprise a halogenated volatile compound. The present invention further includes a method of reducing or preventing pain in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition of the invention. Dosing regimens contemplated within the invention include one-time administration, continuous administration or periodic administration.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: September 11, 2018
    Assignee: Vapogenix, Inc.
    Inventors: Danguole Spakevicius, Heather Giles, Terry Farmer
  • Patent number: 9968540
    Abstract: The present invention provide compositions and methods for treating a dermatological disorder or disease.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: May 15, 2018
    Assignee: Vapogenix, Inc.
    Inventor: Danguole Spakevicius
  • Patent number: 9655867
    Abstract: The present invention provides compositions useful in reducing or preventing pain in a subject in need thereof. In certain embodiments, the compositions comprise a halogenated volatile compound. The present invention further includes a method of reducing or preventing pain in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of at least one composition of the invention. Dosing regimens contemplated within the invention include one-time administration, continuous administration or periodic administration.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: May 23, 2017
    Assignee: Vapogenix, Inc.
    Inventors: Danguole Spakevicius, Heather Giles, Terry Farmer
  • Publication number: 20140199373
    Abstract: The present invention provide compositions and methods for treating a dermatological disorder or disease.
    Type: Application
    Filed: June 21, 2012
    Publication date: July 17, 2014
    Applicant: Vapogenix, Inc.
    Inventor: Danguole Spakevicius
  • Publication number: 20110159078
    Abstract: The present invention provides methods for reducing pain in a subject in need thereof by delivering a volatile anesthetic in a solution or an emulsion that can additionally include an extractive solvent in an amount effective to reduce pain without substantially interfering with motor function. Chronic or acute pain may be treated, or the volatile anesthetic may be delivered as a regional anesthetic to a subject to anesthetize a portion of the subject prior to surgery. Dosing regimes including a one-time administration, continuous and/or periodic administration are contemplated.
    Type: Application
    Filed: January 22, 2009
    Publication date: June 30, 2011
    Applicant: VAPOGENIX, INC
    Inventors: Allen Burton, Phillip C. Phan, Hatice Ozsoy